Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment
Author:
Funder
Gilead Sciences
Abbvie
AASLD
Merck
Janssen
GlaxoSmithKline
ViiV Healthcare
Bristol Myers-Squibb
Conatus
CymaBay
Exalenz
Galectin
Genfit
Gilead
Intercept
Immuron
NGMBio
Novartis
Shire
Publisher
Elsevier BV
Subject
Hepatology
Reference26 articles.
1. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review;Falade-Nwulia;Ann Intern Med,2017
2. Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease;Backus;Hepatology,2018
3. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma;Ioannou;J Hepatol,2017
4. Patient-reported outcomes following treatment of chronic hepatitis C virus infection with sofosbuvir and velpatasvir, with or without voxilaprevir;Younossi;Clin Gastroenterol Hepatol,2018
5. Serum biomarkers indicate long-term reduction in liver fibrosis in patients with sustained virological response to treatment for HCV infection;Lu;Clin Gastroenterol Hepatol,2016
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis;BMC Gastroenterology;2024-01-30
2. CLINICAL PROFILE AND TREATMENT RESPONSE TO SOFOSBUVIR-VELPATASVIR REGIMEN AND ITS IMPACT ON THE QUALITY OF LIFE IN CHRONIC HEPATITIS C PATIENTS;International Journal of Pharmacy and Pharmaceutical Sciences;2023-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3